Search Results

Filter
  • 1-10 of  4,398 results for ""Interferon-alpha""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Report

Interferon Alpha Therapy in MSMD.

  • Authors : Iyengar VV; Department of immunology, Bai Jerbai Wadia Hospital for Children, Acharya Dhonde Marg, Parel, Mumbai, Maharashtra, 400012, India.; Chougule A

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use; Humans ; Male

  • Source: Journal of clinical immunology [J Clin Immunol] 2024 Aug 09; Vol. 44 (8), pp. 174. Date of Electronic Publication: 2024 Aug 09.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Predictive models for functional cure in patients with CHB receiving PEG-IFN therapy based on HBsAg quantification through meta-analysis.

  • Authors : Zhang PX; Department of Infectious Diseases, The Second Affiliated Hospital of Anhui Medical University, 678 Furong Road, Hefei, 230601, China.; Tang QQ

Subjects: Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/blood ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use

  • Source: Hepatology international [Hepatol Int] 2024 Aug; Vol. 18 (4), pp. 1110-1121. Date of Electronic Publication: 2024 Jun 24.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Report

Prevalence of Anti-Interferon α Auto-Antibodies in Patients with Antibody Deficiency.

  • Authors : Fink DL; Institute of Immunity and Transplantation, Division of Infection and Immunity, University College London, London, UK. .; Royal Free London NHS Foundation Trust, London, UK. .

Subjects: Autoantibodies*/Autoantibodies*/Autoantibodies*/immunology ; Autoantibodies*/Autoantibodies*/Autoantibodies*/blood ; Interferon-alpha*

  • Source: Journal of clinical immunology [J Clin Immunol] 2024 Jul 11; Vol. 44 (7), pp. 161. Date of Electronic Publication: 2024 Jul 11.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Predictors of HBsAg seroclearance in patients with chronic HBV infection treated with pegylated interferon-α: a systematic review and meta-analysis.

  • Authors : Jiang S; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.; Guo S

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/therapeutic use ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/drug therapy ; Hepatitis B, Chronic*/Hepatitis B, Chronic*/Hepatitis B, Chronic*/blood

  • Source: Hepatology international [Hepatol Int] 2024 Jun; Vol. 18 (3), pp. 892-903. Date of Electronic Publication: 2024 Mar 09.Publisher: Springer Country of Publication: United States NLM ID: 101304009 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Adipose tissue in COVID-19: detection of SARS-CoV-2 in adipocytes and activation of the interferon-alpha response.

  • Authors : Basolo A; Obesity and Lipodystrophy Center, Endocrinology Unit, University Hospital of Pisa, 56124, Pisa, Italy. .; Poma AM

Subjects: Adipocytes*/Adipocytes*/Adipocytes*/immunology ; Adipose Tissue*/Adipose Tissue*/Adipose Tissue*/immunology ; COVID-19*/COVID-19*/COVID-19*/diagnosis

  • Source: Journal of endocrinological investigation [J Endocrinol Invest] 2022 May; Vol. 45 (5), pp. 1021-1029. Date of Electronic Publication: 2022 Feb 15.Publisher: Springer Country of Publication: Italy NLM ID: 7806594 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Differential Expression of Interferon-Alpha Protein Provides Clues to Tissue Specificity Across Type I Interferonopathies.

  • Authors : Lodi L; Université de Paris, Imagine Institute, Laboratory of Neurogenetics and Neuroinflammation, 24 boulevard du Montparnasse, 75015, Paris, France.; Department of Health Sciences, University of Florence - Meyer Children's University Hospital, Florence, Italy.

Subjects: Disease Susceptibility* ; Gene Expression Regulation*; Interferon Type I/Interferon Type I/Interferon Type I/*genetics

  • Source: Journal of clinical immunology [J Clin Immunol] 2021 Apr; Vol. 41 (3), pp. 603-609. Date of Electronic Publication: 2021 Jan 07.Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Time-dependent recruitment of GAF, ISGF3 and IRF1 complexes shapes IFNα and IFNγ-activated transcriptional responses and explains mechanistic and functional overlap.

  • Authors : Sekrecka A; Human Molecular Genetics Research Unit, Institute of Molecular Biology and Biotechnology, Faculty of Biology, Adam Mickiewicz University, Poznan, Poland.; Kluzek K

Subjects: Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/pharmacology ; Interferon-alpha*/Interferon-alpha*/Interferon-alpha*/genetics ; Interferon Type I*/Interferon Type I*/Interferon Type I*/metabolism

  • Source: Cellular and molecular life sciences : CMLS [Cell Mol Life Sci] 2023 Jun 22; Vol. 80 (7), pp. 187. Date of Electronic Publication: 2023 Jun 22.Publisher: Springer Country of Publication: Switzerland NLM ID: 9705402 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Perspectives on interferon-alpha in the treatment of polycythemia vera and related myeloproliferative neoplasms: minimal residual disease and cure?

  • Authors : Hasselbalch HC; Department of Hematology, Zealand University Hospital, Sygehusvej 10, 4000, Roskilde, Denmark. .; Holmström MO

Subjects: Interferon-alpha/Interferon-alpha/Interferon-alpha/*therapeutic use ; Myeloproliferative Disorders/Myeloproliferative Disorders/Myeloproliferative Disorders/*drug therapy ; Polycythemia Vera/Polycythemia Vera/Polycythemia Vera/*drug therapy

  • Source: Seminars in immunopathology [Semin Immunopathol] 2019 Jan; Vol. 41 (1), pp. 5-19. Date of Electronic Publication: 2018 Sep 10.Publisher: Springer Country of Publication: Germany NLM ID: 101308769 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

  • Authors : Anderson AM; Department of Medicine, Division of Infectious Diseases, Emory University School of Medicine, 341 Ponce de Leon Avenue, Atlanta, GA, 30308, USA. .; Lennox JL

Subjects: AIDS Dementia Complex/AIDS Dementia Complex/AIDS Dementia Complex/*diagnosis ; AIDS Dementia Complex/AIDS Dementia Complex/AIDS Dementia Complex/*immunology ; Antiviral Agents/Antiviral Agents/Antiviral Agents/*therapeutic use

  • Source: Journal of neurovirology [J Neurovirol] 2017 Feb; Vol. 23 (1), pp. 106-112. Date of Electronic Publication: 2016 Jul 11.Publisher: Springer Country of Publication: United States NLM ID: 9508123 Publication Model: Print-Electronic Cited Medium:

Record details

×
Academic Journal

Effect of pegylated interferon alfa-2a in HBeAg-negative chronic hepatitis B during and 48 weeks after off-treatment follow-up: the limitation of pre-treatment HBsAg load for the seroclearance of HBsAg.

  • Authors : Mimura S; Department of Gastroenterology and Neurology, Kagawa University Hospital, Ikenobe Miki-cho, Kita-gun, Kagawa, 761-0793, Japan. .; Fujita K

Subjects: Time Factors*; Hepatitis B/Hepatitis B/Hepatitis B/*blood ; Hepatitis B e Antigens/Hepatitis B e Antigens/Hepatitis B e Antigens/*analysis

  • Source: Internal and emergency medicine [Intern Emerg Med] 2021 Sep; Vol. 16 (6), pp. 1559-1565. Date of Electronic Publication: 2021 Jan 27.Publisher: Springer Country of Publication: Italy NLM ID: 101263418 Publication Model: Print-Electronic Cited Medium:

Record details

×
  • 1-10 of  4,398 results for ""Interferon-alpha""